Pitcairn CO 10x Genomics, Inc. Transaction History
Pitcairn CO
- $1.53 Billion
- Q1 2024
A detailed history of Pitcairn CO transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Pitcairn CO holds 5,648 shares of TXG stock, worth $106,577. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,648
Previous 6,907
18.23%
Holding current value
$106,577
Previous $386,000
45.34%
% of portfolio
0.01%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding TXG
# of Institutions
309Shares Held
92MCall Options Held
267KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA9.1MShares$172 Million0.01% of portfolio
-
Baillie Gifford & CO7.42MShares$140 Million0.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.28MShares$119 Million1.68% of portfolio
-
Black Rock Inc. New York, NY6.01MShares$113 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.16MShares$97.5 Million0.02% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.79B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...